Shinpoong Pharmaceutical Co Ltd (019175) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shinpoong Pharmaceutical Co Ltd (019175) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.36 Billion ≈ $4.31 Million USD) by net assets (₩292.26 Billion ≈ $198.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shinpoong Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.
Shinpoong Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Shinpoong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shinpoong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shinpoong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Shinpoong Pharmaceutical Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eastern Metals Ltd
AU:EMS
|
-0.397x |
|
Shreyans Industries Limited
NSE:SHREYANIND
|
0.040x |
|
Jui Li Enterprise Co Ltd
TW:1512
|
0.012x |
|
Liberty TripAdvisor Holdings, Inc
NASDAQ:LTRPA
|
-0.012x |
|
Masterkool International Public Company Limited
BK:KOOL
|
0.153x |
|
FGI Industries Ltd
NASDAQ:FGI
|
0.142x |
|
Southern Fertilizer JSC
VN:SFG
|
0.325x |
|
London City Equities Ltd
AU:LCE
|
-0.198x |
Annual Cash Flow Conversion Efficiency for Shinpoong Pharmaceutical Co Ltd (2014–2025)
The table below shows the annual cash flow conversion efficiency of Shinpoong Pharmaceutical Co Ltd from 2014 to 2025. View current stock price of Shinpoong Pharmaceutical Co Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩270.73 Billion ≈ $183.47 Million |
₩17.25 Billion ≈ $11.69 Million |
0.064x | +208.54% |
| 2024-12-31 | ₩258.09 Billion ≈ $174.90 Million |
₩-15.15 Billion ≈ $-10.27 Million |
-0.059x | +35.91% |
| 2023-12-31 | ₩270.78 Billion ≈ $183.51 Million |
₩-24.81 Billion ≈ $-16.81 Million |
-0.092x | -14.59% |
| 2022-12-31 | ₩330.76 Billion ≈ $224.15 Million |
₩-26.44 Billion ≈ $-17.92 Million |
-0.080x | +60.09% |
| 2021-12-31 | ₩354.56 Billion ≈ $240.28 Million |
₩-71.03 Billion ≈ $-48.13 Million |
-0.200x | -473.78% |
| 2020-12-31 | ₩374.33 Billion ≈ $253.68 Million |
₩20.06 Billion ≈ $13.60 Million |
0.054x | -42.08% |
| 2019-12-31 | ₩209.13 Billion ≈ $141.72 Million |
₩19.35 Billion ≈ $13.11 Million |
0.093x | -40.11% |
| 2018-12-31 | ₩207.48 Billion ≈ $140.61 Million |
₩32.05 Billion ≈ $21.72 Million |
0.154x | +219.87% |
| 2017-12-31 | ₩210.11 Billion ≈ $142.39 Million |
₩10.15 Billion ≈ $6.88 Million |
0.048x | -44.76% |
| 2016-12-31 | ₩216.85 Billion ≈ $146.96 Million |
₩18.96 Billion ≈ $12.85 Million |
0.087x | +72.25% |
| 2015-12-31 | ₩194.86 Billion ≈ $132.05 Million |
₩9.89 Billion ≈ $6.70 Million |
0.051x | +20285.41% |
| 2014-12-31 | ₩191.51 Billion ≈ $129.79 Million |
₩-48.16 Million ≈ $-32.64K |
0.000x | -- |
About Shinpoong Pharmaceutical Co Ltd
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more